Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jacqueline McCarty

Physician Assistant, Medical South Charleston, WV Physician Assistant

NPI 1295017473 CMS profile 11099638

4815 Kanawha Ave Sw, South Charleston, WV 25309

Open in the dashboard

General payments

$5,125

282 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jacqueline McCarty of South Charleston, WV is reported in the CMS Open Payments database as having received $5,125 across 282 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,518 81
2024 General $1,606 80
2023 General $1,329 77
2022 General $395 34
2021 General $276 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacqueline McCarty
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Jacqueline McCarty were reported at $1,518. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Jacqueline McCarty Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $276 $156 $41–$563 $132
2022 $395 $185 $55–$649 $149
2023 $1,329 $199 $58–$717 $160
2024 $1,606 $206 $62–$740 $164
2025 $1,518 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,236 84 payments
  2. Janssen Biotech, Inc. $1,062 56 payments
  3. E.R. Squibb & Sons, L.L.C. $562 31 payments
  4. Regeneron Healthcare Solutions, Inc. $296 11 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $282 16 payments
  6. Novartis Pharmaceuticals Corporation $256 13 payments
  7. Lilly USA, LLC $242 17 payments
  8. Incyte Corporation $173 6 payments
  9. Galderma Laboratories, L.P. $156 14 payments
  10. Organon LLC $149 2 payments
  11. Other $710 32 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,798 277 payments
  2. Education $327 5 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $1,075 57 payments
  2. RINVOQ $649 46 payments
  3. SOTYKTU $554 30 payments
  4. SKYRIZI Immunology $408 25 payments
  5. TALTZ $242 17 payments
  6. DUPIXENT Immunology $201 9 payments
  7. DUPIXENT Inflammation And Immunology $176 7 payments
  8. SKYRIZI Immunology $174 12 payments
  9. OPZELURA $173 6 payments
  10. SPEVIGO $156 8 payments
  11. Other $1,446 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

669

Median for Physician Assistant: 241

Drug cost

$14,883

Median for Physician Assistant: $4,110

Branded share of claims

1.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 107 $3,169
Fluorouracil Generic 37 $2,363
Triamcinolone Acetonide Generic 137 $1,471
Ketoconazole Generic 73 $1,352
Tretinoin Generic 15 $1,231
Metronidazole Generic 23 $1,167
Fluocinonide Generic 28 $936
Doxycycline Hyclate Generic 63 $913
Mupirocin Generic 116 $775
Clindamycin Phosphate Generic 30 $757

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$76,718

Medicare's payments for the services billed

Medicare patients

514

Average age 73

Services billed

3,172

255 women, 259 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 38%
Ischemic heart disease 35%
Chronic kidney disease 27%
Depression 23%
COPD 14%
Cancer 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 17 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $463
$463 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $322
$322 — —
RINVOQ
  • AbbVie, Inc. $189
$189 — —
SKYRIZI
  • AbbVie, Inc. $156
$156 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $88
  • GENZYME CORPORATION $16
$104 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 17 in the dashboard with a free account

Records

282 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record